Fusion Pharmaceuticals Inc. Deferred Offering Costs
Fusion Pharmaceuticals Inc. had Deferred Offering Costs of $0 as of 2023-12-31, per its 10-K filed 2024-03-20.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:DeferredOfferingCosts · last filed 2024-03-20
- 2023-12-31: Deferred Offering Costs $0.00.
- 2023-09-30: Deferred Offering Costs $100.00K.
- 2023-06-30: Deferred Offering Costs $100.00K.
- 2023-03-31: Deferred Offering Costs $200.00K.
| Period end | Deferred Offering Costs | Deferred Offering Costs as first filed |
|---|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-03-20 | |
| 2023-09-30 | $100.00K 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $100.00K 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $200.00K 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $200.00K 10-K · filed 2024-03-20 | |
| 2022-09-30 | $200.00K 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $300.00K 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $300.00K 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $300.00K 10-K · filed 2023-03-16 | |
| 2021-09-30 | $300.00K 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $300.00K 10-Q · filed 2021-08-10 | |
| 2020-12-31 | $300.00K 10-Q · filed 2022-08-09 | $0.00 10-K · filed 2021-03-25 |
| 2020-09-30 | $0.00 10-Q · filed 2020-11-10 | |
| 2020-06-30 | $0.00 10-Q · filed 2020-08-11 | |
| 2019-12-31 | $0.00 10-K · filed 2021-03-25 |